Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 2
Submit an article Journal homepage
383
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of encorafenib for the treatment of melanoma

Michael J. CarrDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAORCID Iconhttps://orcid.org/0000-0001-6233-4004View further author information
ORCID Icon,
James SunDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAView further author information
,
Zeynep ErogluDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAView further author information
&
Jonathan S. ZagerDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USACorrespondence[email protected]
View further author information
Pages 155-161 | Received 27 Aug 2019, Accepted 14 Nov 2019, Published online: 30 Nov 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhiyong Xiao, Feng Liu, Junping Cheng, Ying Wang, Wenxia Zhou & Yongxiang Zhang. (2023) B-Raf inhibitor vemurafenib counteracts sulfur mustard-induced epidermal impairment through MAPK/ERK signaling. Drug and Chemical Toxicology 46:2, pages 226-235.
Read now
Erin McClure, Ayushi Patel, Michael J. Carr, James Sun & Jonathan S. Zager. (2021) The combination of encorafenib and binimetinib for the treatment of patients with BRAF-mutated advanced, unresectable, or metastatic melanoma: an update. Expert Review of Precision Medicine and Drug Development 6:1, pages 19-29.
Read now

Articles from other publishers (8)

Ava Bachari, Nazim Nassar, Srinivasareddy Telukutla, Roby Zomer, Chaitali Dekiwadia, Terrence J. Piva & Nitin Mantri. (2023) In Vitro Antiproliferative Effect of Cannabis Extract PHEC-66 on Melanoma Cell Lines. Cells 12:20, pages 2450.
Crossref
Maria Russi, Rachele Valeri, Domenico Marson, Chiara Danielli, Fulvia Felluga, Aura Tintaru, Natasa Skoko, Suzana Aulic, Erik Laurini & Sabrina Pricl. (2023) Some things old, new and borrowed: Delivery of dabrafenib and vemurafenib to melanoma cells via self-assembled nanomicelles based on an amphiphilic dendrimer. European Journal of Pharmaceutical Sciences 180, pages 106311.
Crossref
Xiaochu Tong, Dingyan Wang, Xiaoyu Ding, Xiaoqin Tan, Qun Ren, Geng Chen, Yu Rong, Tingyang Xu, Junzhou Huang, Hualiang Jiang, Mingyue Zheng & Xutong Li. (2022) Blood–brain barrier penetration prediction enhanced by uncertainty estimation. Journal of Cheminformatics 14:1.
Crossref
I. Anestopoulos, S. Kyriakou, V. Tragkola, I. Paraskevaidis, E. Tzika, M. Mitsiogianni, M.V. Deligiorgi, G. Petrakis, D.T. Trafalis, S. Botaitis, A. Giatromanolaki, M.I. Koukourakis, R. Franco, A. Pappa & M.I. Panayiotidis. (2022) Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacology & Therapeutics 240, pages 108301.
Crossref
Alexander Nirenberg, Howard Steinman & Anthony Dixon. (2021) Keratoacanthoma: Update on the Debate. The American Journal of Dermatopathology 43:4, pages 305-307.
Crossref
Zhenqing Sun, Zhigang Qiu, Bin Ma & Zhengkun Wang. (2020) Encorafenib enhances TRAIL-induced apoptosis of colorectal cancer cells dependent on p53/PUMA signaling. Cytotechnology 73:1, pages 63-70.
Crossref
Sanjeev Kumar, Ekta Lathwal, Gourav Kumar, Bhavna Saroha, Suresh Kumar, Sutapa Mahata, Pranab Kumar Sahoo & Vilas D. Nasare. (2020) Synthesis of pyrazole based novel aurone analogs and their cytotoxic activity against MCF-7 cell line. Chemical Data Collections 30, pages 100559.
Crossref
Ioannis Anestopoulos, Sotiris Kyriakou, Venetia Tragkola, Ioannis Paraskevaidis, Eleni Tzika, Melina Mitsiogianni, Maria Deligiorgi, Giorgos Petrakis, Dimitrios T. Trafalis, Sotiris Botaitis, Alexandra Giatromanolaki, Michail I. Koukourakis, Franco Rodrigo, Aglaia Pappa & Mihalis Panagiotidis. (2022) Targeting the Epigenome in Malignant Melanoma: Facts, Challenges and Therapeutic Promises. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.